188 related articles for article (PubMed ID: 16480404)
1. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
Vakil N; Guda N; Partington S
Aliment Pharmacol Ther; 2006 Mar; 23(5):649-53. PubMed ID: 16480404
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
3. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
4. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
5. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
6. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
Abu Farsakh N
J Gastroenterol; 2003; 38(11):1042-8. PubMed ID: 14673720
[TBL] [Abstract][Full Text] [Related]
8. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.
Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R
Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198
[TBL] [Abstract][Full Text] [Related]
11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
Harasawa S
Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
14. Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure.
Katz PO
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():31-8. PubMed ID: 16303035
[TBL] [Abstract][Full Text] [Related]
15. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn.
Rodriguez-Stanley S; Ciociola AA; Zubaidi S; Proskin HM; Miner PB
Aliment Pharmacol Ther; 2004 Nov; 20(9):975-82. PubMed ID: 15521845
[TBL] [Abstract][Full Text] [Related]
16. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2007 May; 39(5):415-21. PubMed ID: 17379591
[TBL] [Abstract][Full Text] [Related]
17. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
Mitchell RM; Collins JS; Watson RG; Tham TC
Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
[TBL] [Abstract][Full Text] [Related]
18. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
Pipkin GA; Mills JG
Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
[TBL] [Abstract][Full Text] [Related]
19. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
Kahrilas PJ; Fennerty MB; Joelsson B
Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
[TBL] [Abstract][Full Text] [Related]
20. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
Lambert R
J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
[No Abstract] [Full Text] [Related]
[Next] [New Search]
